Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 49 articles: HTML format

Single Articles

February 2021
1. YANAGAWA N, Shiono S, Endo M, Ogata SY, et al
   Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma.
   Hum Pathol. 2021;108:12-21.
   PubMed     Abstract available
   
   
   December 2020
2. LAFLAMME P, Mansoori BK, Sazanova O, Orain M, et al
   Phospho-histone-H3 immunostaining for pulmonary carcinoids: impact on clinical appraisal, interobserver correlation, and diagnostic processing efficiency.
   Hum Pathol. 2020;106:74-81.
   PubMed     Abstract available
   
   
   November 2020
3. LIU L, Wei J, Teng F, Zhu Y, et al
   Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited stage after surgery.
   Hum Pathol. 2020 Nov 24. pii: S0046-8177(20)30235.
   PubMed     Abstract available
   
   
   
4. REN HZ, Cheung S, Churg A
   c-MET immunohistochemistry for differentiating malignant mesothelioma from benign mesothelial proliferations.
   Hum Pathol. 2020;105:31-36.
   PubMed     Abstract available
   
   
   
5. PRABHAKARAN S, Hocking A, Kim C, Hussey M, et al
   The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
   Hum Pathol. 2020;105:1-8.
   PubMed     Abstract available
   
   
   September 2020
6. HERMELIJN SM, Wolf JL, Dorine den Toom T, Wijnen RMH, et al
   Early KRAS oncogenic driver mutations in nonmucinous tissue of congenital pulmonary airway malformations as an indicator of potential malignant behavior.
   Hum Pathol. 2020;103:95-106.
   PubMed     Abstract available
   
   
   
7. HAYASHI T, Kohsaka S, Takamochi K, Hara K, et al
   Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations.
   Hum Pathol. 2020;103:42-51.
   PubMed     Abstract available
   
   
   April 2020
8. NASO JR, Churg A
   Claudin-4 Shows Superior Specificity for Mesothelioma vs Non-Small Cell Lung Carcinoma Compared to MOC-31 and Ber-EP4.
   Hum Pathol. 2020 Apr 22. pii: S0046-8177(20)30077.
   PubMed     Abstract available
   
   
   
9. MORAN CA, Lindholm KE, Brunnstrom H, Langman G, et al
   Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.
   Hum Pathol. 2020;98:98-109.
   PubMed     Abstract available
   
   
   
10. PAAJANEN J, Laaksonen S, Kettunen E, Ilonen I, et al
    Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival.
    Hum Pathol. 2020;98:110-119.
    PubMed     Abstract available
    
    
    March 2020
11. CHEN L, Cao MF, Xiao JF, Ma QH, et al
    Stromal PD-1(+) tumor-associated macrophages predict poor prognosis in lung adenocarcinoma.
    Hum Pathol. 2020;97:68-79.
    PubMed     Abstract available
    
    
    January 2020
12. DEFTEREOS G, Sandoval A, Furtado LV, Bronner M, et al
    Successful lung Cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue.
    Hum Pathol. 2020 Jan 21. pii: S0046-8177(20)30014.
    PubMed     Abstract available
    
    
    August 2019
13. KRENCZ I, Sebestyen A, Papay J, Lou Y, et al
    Correlation between immunohistochemistry and RICTOR FISH amplification in small cell lung carcinoma.
    Hum Pathol. 2019 Aug 24. pii: S0046-8177(19)30157.
    PubMed     Abstract available
    
    
    July 2019
14. BUTNOR KJ, Pavlisko EN, Sporn TA, Roggli VL, et al
    Mesothelioma of the tunica vaginalis testis.
    Hum Pathol. 2019 Jul 31. pii: S0046-8177(19)30133.
    PubMed     Abstract available
    
    
    May 2019
15. MUNARI E, Zamboni G, Lunardi G, Marconi M, et al
    PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays.
    Hum Pathol. 2019 May 20. pii: S0046-8177(19)30088.
    PubMed     Abstract available
    
    
    
16. BOURHIS A, Quintin-Roue I, Uguen A
    About concomitant KRAS and other molecular alterations in non-small cell lung cancers.
    Hum Pathol. 2019;87:115-116.
    PubMed    
    
    
    
17. CHAPEL DB, Stewart R, Furtado LV, Husain AN, et al
    Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
    Hum Pathol. 2019;87:11-17.
    PubMed     Abstract available
    
    
    April 2019
18. HUNG YP, Hunninghake GM, Miller ER, Putman R, et al
    Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.
    Hum Pathol. 2019;86:93-101.
    PubMed     Abstract available
    
    
    
19. WANG Y, Piao J, Wang Q, Cui X, et al
    Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3beta pathway in lung adenocarcinoma.
    Hum Pathol. 2019;86:233-242.
    PubMed     Abstract available
    
    
    March 2019
20. ZHANG J, Sun J, Zhang Z, Wang A, et al
    Driver mutation profiles and clinicopathological correlation in pulmonary adenocarcinoma with a micropapillary component.
    Hum Pathol. 2019;85:242-250.
    PubMed     Abstract available
    
    
    
21. LINDHOLM KE, Kalhor N, Moran CA
    Osteoclast-like giant cell-rich carcinomas of the lung: a clinicopathological, immunohistochemical, and molecular study of 3 cases.
    Hum Pathol. 2019;85:168-173.
    PubMed     Abstract available
    
    
    
22. SVAJDLER M, Mezencev R, Saskova B, Ondic O, et al
    Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology
    Hum Pathol. 2019;85:58-64.
    PubMed     Abstract available
    
    
    February 2019
23. KAIRA K, Kawashima O, Endoh H, Imaizumi K, et al
    Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Hum Pathol. 2019;84:142-149.
    PubMed     Abstract available
    
    
    
24. SHAUKAT I, Kern JJ, Hoti N, Zhang H, et al
    Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics.
    Hum Pathol. 2019;84:18-25.
    PubMed     Abstract available
    
    
    January 2019
25. BIAN T, Jiang D, Feng J, Liu J, et al
    Lepidic component at tumor margin: an independent prognostic factor in invasive lung adenocarcinoma.
    Hum Pathol. 2019;83:106-114.
    PubMed     Abstract available
    
    
    October 2018
26. VIDARSDOTTIR H, Tran L, Nodin B, Jirstrom K, et al
    Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Hum Pathol. 2018 Oct 30. pii: S0046-8177(18)30396.
    PubMed     Abstract available
    
    
    September 2018
27. MACHADO-RUGOLO J, Fabro AT, Ascheri D, Farhat C, et al
    Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting a treatment outcomes of non-small cell lung cancer.
    Hum Pathol. 2018 Sep 12. pii: S0046-8177(18)30352.
    PubMed     Abstract available
    
    
    August 2018
28. CHEN X, Shao W, Huang H, Feng X, et al
    Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Hum Pathol. 2018 Aug 30. pii: S0046-8177(18)30329.
    PubMed     Abstract available
    
    
    July 2018
29. ZHANG M, Li G, Sun X, Ni S, et al
    MET amplification, expression, and exon 14 mutations in colorectal adenocarcinoma.
    Hum Pathol. 2018;77:108-115.
    PubMed     Abstract available
    
    
    
30. LIU J, Lu F, Gong Y, Zhao C, et al
    High expression of synthesis of cytochrome c oxidase 2 and TP53-induced glycolysis and apoptosis regulator can predict poor prognosis in human lung adenocarcinoma.
    Hum Pathol. 2018;77:54-62.
    PubMed     Abstract available
    
    
    
31. PYO JS, Park MJ, Kang DW
    The clinicopathological significance of micropapillary pattern in colorectal cancers.
    Hum Pathol. 2018;77:159-165.
    PubMed     Abstract available
    
    
    June 2018
32. RAKAEE M, Kilvaer TK, Dalen SM, Richardsen E, et al
    Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Hum Pathol. 2018 Jun 6. pii: S0046-8177(18)30185.
    PubMed     Abstract available
    
    
    February 2018
33. BOSCH DE, Farjah F, Wood DE, Schmidt RA, et al
    Regional lymph node sampling in lung carcinoma: a single institutional and national database comparison.
    Hum Pathol. 2018 Feb 12. pii: S0046-8177(18)30042.
    PubMed     Abstract available
    
    
    
34. HAYASHI T, Takamochi K, Yanai Y, Mitani K, et al
    Non-small cell lung carcinoma with diffuse co-expression of thyroid transcription factor-1 and DeltaNp63/p40.
    Hum Pathol. 2018 Feb 1. pii: S0046-8177(18)30037.
    PubMed     Abstract available
    
    
    
35. XING D, Banet N, Sharma R, Vang R, et al
    Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
    Hum Pathol. 2018;72:160-166.
    PubMed     Abstract available
    
    
    
36. ZHANG J, Sun J, Zhang Z, Liang X, et al
    Protein overexpression and gene amplification of cellular mesenchymal-epithelial transition factor is associated with poor prognosis in micropapillary-predominant subtype pulmonary adenocarcinoma.
    Hum Pathol. 2018;72:59-65.
    PubMed     Abstract available
    
    
    January 2018
37. BOLAND JM, Maleszewski JJ, Wampfler JA, Voss JS, et al
    Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
    Hum Pathol. 2018;71:8-19.
    PubMed     Abstract available
    
    
    
38. INAGUMA S, Lasota J, Wang Z, Czapiewski P, et al
    Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.
    Hum Pathol. 2018;71:1-7.
    PubMed     Abstract available
    
    
    October 2017
39. RIGHI A, Mancini I, Gambarotti M, Picci P, et al
    Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Hum Pathol. 2017;68:128-135.
    PubMed     Abstract available
    
    
    
40. YEO MK, Choi SY, Seong IO, Suh KS, et al
    Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Hum Pathol. 2017;68:103-111.
    PubMed     Abstract available
    
    
    September 2017
41. NELSON ER, Sharma R, Argani P, Cimino-Mathews A, et al
    Utility of Sox10 labeling in metastatic breast carcinomas.
    Hum Pathol. 2017;67:205-210.
    PubMed     Abstract available
    
    
    
42. MARCHEVSKY AM, LeStang N, Hiroshima K, Pelosi G, et al
    The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
    Hum Pathol. 2017;67:160-168.
    PubMed     Abstract available
    
    
    August 2017
43. TANAKA M, Kohashi K, Kushitani K, Yoshida M, et al
    Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.
    Hum Pathol. 2017;66:177-182.
    PubMed     Abstract available
    
    
    
44. FRYDENLUND N, Mahalingam M
    PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.
    Hum Pathol. 2017;66:13-33.
    PubMed     Abstract available
    
    
    
45. MOLINA-ROMERO C, Rangel-Escareno C, Ortega-Gomez A, Alanis-Funes GJ, et al
    Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
    Hum Pathol. 2017;66:188-199.
    PubMed     Abstract available
    
    
    June 2017
46. MATSUSHIMA J, Yazawa T, Suzuki M, Takahashi Y, et al
    Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Hum Pathol. 2017;64:179-185.
    PubMed     Abstract available
    
    
    May 2017
47. YVOREL V, Forest F, Karpathiou G, Peoc'h M, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung-reply.
    Hum Pathol. 2017;63:220-221.
    PubMed    
    
    
    
48. MENGOLI MC, Bettelli S, Gasparri P, Bertolini F, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung.
    Hum Pathol. 2017;63:218-220.
    PubMed    
    
    
    April 2017
49. KRENCZ I, Sebestyen A, Fabian K, Mark A, et al
    Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma.
    Hum Pathol. 2017;62:66-73.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: